Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Accounts Payables (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Accounts Payables came in at $402311.0 in Q1 2026, down 52.0% YoY from $838184.0 in Q1 2025, and down 63.1% on a QoQ basis from $1.1 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Accounts Payables (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Accounts Payables data on file, last reported at $402311.0 in Q1 2026.

  • Quarterly Accounts Payables fell 52.0% year-over-year to $402311.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $402311.0 (down 52.0% YoY) and the FY2025 annual result came in at $1.1 million, changed 0.06% from the prior year.
  • Accounts Payables eased to $402311.0 in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.1 million in Q2 2023 to a low of $100000.0 in Q2 2025.
  • A 5-year average of $782106.2 and a median of $784029.0 in 2024 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2023 — Accounts Payables jumped 112.11% — and 2025, when it tumbled 87.25%.
  • Tracing CNTN's Accounts Payables over 5 years: stood at $954505.0 in 2022, then fell by 4.81% to $908577.0 in 2023, then gained by 19.93% to $1.1 million in 2024, then climbed by 0.06% to $1.1 million in 2025, then plunged by 63.1% to $402311.0 in 2026.
  • The last three Accounts Payables figures came in at $402311.0 (Q1 2026), $1.1 million (Q4 2025), and $659254.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 916,244.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 916,244.00
Mar 31, 2026 402,311.00
Dec 31, 2025 521,201.00
Sep 30, 2025 659,254.00
Jun 30, 2025 770,610.00
Mar 31, 2025 838,184.00
Dec 31, 2024 1.09 Mn
Sep 30, 2024 783,839.00
Jun 30, 2024 784,029.00
Mar 31, 2024 993,244.00
Dec 31, 2023 908,577.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 1.14 Mn
Mar 31, 2023 718,990.00
Dec 31, 2022 954,505.00
Sep 30, 2022 536,838.00
Jun 30, 2022 559,529.00
Mar 31, 2022 597,455.00
Dec 31, 2021 1.46 Mn
Dec 31, 2020 514,828.00